Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05630547
What this trial is testing

Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 174
Not applicableActive Not RecruitingNCT05351333
What this trial is testing

Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Who this might be right for
Spinal Cord InjuriesPolytraumaBurns
Spaulding Rehabilitation Hospital 66
Testing effectiveness (Phase 2)Study completedNCT04236440
What this trial is testing

Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration

Who this might be right for
Sleep Apnea, Obstructive
Bayer 14
Testing effectiveness (Phase 2)Study completedNCT01222117
What this trial is testing

Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Who this might be right for
Acute Peripheral Arterial Occlusion
Grifols Therapeutics LLC 174
Large-scale testing (Phase 3)WithdrawnNCT06260748
What this trial is testing

Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)

Who this might be right for
Cerebrotendinous Xanthomatoses
Leadiant Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT02603614
What this trial is testing

Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment

Who this might be right for
Heart FailureRenal Insufficiency
Capricor Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01590459
What this trial is testing

24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 359
Large-scale testing (Phase 3)Study completedNCT01066442
What this trial is testing

Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Bioprojet 273
Large-scale testing (Phase 3)Study completedNCT00210769
What this trial is testing

The Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203
Large-scale testing (Phase 3)Study completedNCT01136954
What this trial is testing

Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)

Who this might be right for
Partial Seizures
Eisai Limited 144
Large-scale testing (Phase 3)Study completedNCT00225797
What this trial is testing

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

Who this might be right for
Chronic Pain
Endo USA Inc., a Keenova Therapeutics Company 160
Early research (Phase 1)Study completedNCT05521191
What this trial is testing

RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseADPKDPolycystic Kidney, Autosomal Dominant
Regulus Therapeutics Inc. 68
Testing effectiveness (Phase 2)Study completedNCT06644924
What this trial is testing

A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma

Who this might be right for
Asthma
AstraZeneca 118
Early research (Phase 1)Study completedNCT02461160
What this trial is testing

Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

Who this might be right for
Healthy Volunteers
Takeda 88
Large-scale testing (Phase 3)Study completedNCT03985982
What this trial is testing

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Who this might be right for
Glabellar Frown Lines
Croma-Pharma GmbH 410
Large-scale testing (Phase 3)Study completedNCT03173391
What this trial is testing

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Hua Medicine Limited 463
Large-scale testing (Phase 3)Ended earlyNCT03567291
What this trial is testing

Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents

Who this might be right for
Tourette Syndrome
Teva Branded Pharmaceutical Products R&D, Inc. 228
Large-scale testing (Phase 3)Study completedNCT04533529
What this trial is testing

Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 588
Large-scale testing (Phase 3)Study completedNCT00549939
What this trial is testing

Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction

Who this might be right for
Neurogenic Urinary Bladder
Sanofi 172
Testing effectiveness (Phase 2)Study completedNCT02078219
What this trial is testing

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia

Who this might be right for
Gout and Hyperuricemia
AstraZeneca 204
Next Page